Awareness and Adherence of Proprietary Patent Medicine Vendors to Malaria Rapid Diagnostic Test in Nigeria: A Cross-Sectional Study

References

[1] WHO, “The use of Anti-Malaria Drugs, Report of a WHO informal Consultation, WHO, Geneva,” 2001.

[2] Federal Ministry of Health, “Strategic Plan for Rolling Back Malaria in Nigeria,” 2012.

[3] WHO, “Implemetation of General Assembly resolution 66/289 on consolidating gains and accelerating efforst to contro and eliminate malaria in developing coountries, particularly in Africa, by 2015,” 2013.

[4] W. R. Breiger, P. E. Osamor, K. S. Salami, O. Oladepa, and S. A. Ofusanya, “Observations of Patent Medicine Vendor and Customer interactions in Urban and Rural areas of Oyo State, Nigeria.,” Heal. Policy Planning., vol. 19, no. 3, pp. 177–182, 2004.

[5] A. D. Okonkwo and U. . Okonkwo, “Patent medicine vendors, community pharmacists and STI management in Abuja, Nigeria.,” Afri Heal. Sci, vol. 10, no. 1, pp. 253–265, 2010.

[6] A. S. Oyeyemi, B. E. Ogunnowo, and O. O. Odukoya, “Patent Medicine Vendors in Rural Areas of Lagos Nigeria: Compliance with Regulatory Guidelines and Implications for Malaria Control.,” Trop. J. Pharm. Res., vol. 13, no. 1, pp. 163–169, 2004.

[7] P. N. Aniebue, E. N. Aguwa, and E. I. Obi, “Universal Precautions: awareness and practice of patent medicine vendors in Enugu metropolis, South East Nigeria.,” Niger Med J, vol. 51, no. 1, pp. 30–34, 2010.

[8] C. Goodman, S. P. Kachur, S. Abdulla, P. Bloland, and A. Mills, “Drug shop regulation and malaria treatment in Tanzania—why do shops break the rules, and does it matter?,” Heal. Policy Plan, vol. 22, no. 1, pp. 393–403, 2007.

[9] I. O. Ajayi, T. Soyannwo, and O. M. Akpa, “Awareness and utilization of affordable medicine facility-malaria among caregivers of under-five children in Ibadan north-west local government area, Oyo state.,” Malar. Res. Treat., vol. 23, no. 1, pp. 25–39, 2013.

[10] P. W. Gething, V. C. Kirui, V. A. Alegana, E. A. Okiro, A. M. Noor, and R. W. Snow, “Estimating the number of paediatric fevers associated with malaria infection presenting to Africa’s public health sector in 2007.,” PLoS Med. 7(7)., vol. 7, no. 7, 2010.

[11] T. O. Abuya, W. Mutemi, B. Karisa, S. Ochola, G. Fegan, and V. Marsh, “Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: Implications for private medicine retailer interventions.,” Malar. J., vol. 6, no. 57, pp. 60–78, 2007.

[12] P. Ndyomuoyenyi, R. Magnussen and C. Sian, “Malaria Treatment-Seeking Behavior and Drug Prescriptions Practices in an Area of Low transmission in Uganda: Implications for Prevention and Control.,” Trans. R. Soc. Trop. Med. Hyg., vol. 101, no. 2, pp. 209–215, 2007.

[13] T. A. Okeke, B. S. Uzochukwu, and H. U. Okafor, “An In-depth study of Patent Medicine Sellers Perspectives on Malaria in a Rural Nigerian Community.,” Malar. J., vol. 5, no. 1, p. 97, 2006.

@article{1703539,
      author = {Akinreni Temidayo Ifeoluwa, Ogbobe Joy Ukamaka},
      title = {Awareness and Adherence of Proprietary Patent Medicine Vendors to Malaria Rapid Diagnostic Test in Nigeria: A Cross-Sectional Study},
      journal = {Iconic Research And Engineering Journals},
      year = {2022},
      volume = {5},
      number = {12},
      pages = {190-195},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1703539.pdf},
      abstract = {Background: Proprietary Patent Medicine Vendors (PPMV) have been identified as a widely patronized source for drugs used in the home treatment of malaria. The presence of PPMVs has increased sales and recommendation of antimalarial drugs among Nigeria populace. This study was conducted to assess the awareness and adherence of Proprietary Patent Medicine Vendor to Rapid Diagnostic Test in Ondo state, Nigeria. 
Methods: A descriptive cross-sectional study comprising 192 registered Proprietary Patent Medicine Vendors who were selected via multistage sampling method. Relevant data collected via semi-structured questionnaire and analysed using IBM SPSS 23.0
Results: The mean age for the respondents was 38years. Majority of the respondents have heard of RDT (85.9%), while 75.0% know about the malaria treatment policy. The study also reveals that arthemeter was the most familiar drug among respondents. Also, 83.3% of respondents believed the use of RDT has improved the treatment of malaria. 
Conclusion: Awareness of malaria testing and treatment policy was high, but adherence was unsatisfactory. Thus, there is need to provide vendors with competency-based training and supervision to improve the awareness and adherence which would enhance the quality of care they provide.},
      keywords = {Adherence, Arthemeter, Awareness, Proprietary Patent Medicine Vendors, Rapid Diagnostic Test},
      month = {June},
  }